Assignee
WNTRX PHARMACEUTICALS INC
US·4 granted patents·1 pending application·6 citations·filing 2016–2023
Top patents by PatentIndex Score
5 records- 0187US11498947B2Stabilized BCL9 peptides for treatment of aberrant WNT signalingWNTRX PHARMACEUTICALS INC·Filed 2021·Granted Nov 15, 2022·2 cites·20 claims
- 0283US10961290B2Stabilized BCL9 peptides for treatment of aberrant WNT signalingWNTRX PHARMACEUTICALS INC·Filed 2016·Granted Mar 30, 2021·3 cites·11 claims
- 0372US12264185B2Stabilized BCL9 peptides for treatment of aberrant Wnt signalingWNTRX PHARMACEUTICALS INC·Filed 2022·Granted Apr 1, 2025·0 cites·10 claims
- 0470US11591365B2BCL9 peptides and variants thereofWNTRX PHARMACEUTICALS INC·Filed 2018·Granted Feb 28, 2023·1 cites·11 claims
- 0570US2024317803A1Bcl9 peptides and variants thereofWNTRX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when WNTRX PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →